Altimmune, Inc. — Director's Dealing 2012

Mar 8, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PHARMATHENE, INC (PIP)
CIK: 0001326190
Period of Report: 2012-03-07

Reporting Person: RICHMAN ERIC I (Director, See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-07	Common Stock, $0.0001 par value per share	F	22500	—	Disposed	176822	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value per share	10000	Indirect

Footnotes

F1: Shares withheld at vesting of restricted stock for purposes of meeting the Reporting Person's tax obligations. The closing price of the issuer's common stock on the NYSE Amex on 3/7/2012 was $1.28.

F2: Held indirectly as previously reported on Form 4 dated 11/10/11.